Cesca Therapeutics to Present at the 2017 Marcum MicroCap Conference
June 12 2017 - 1:00PM
Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated
cell processing and point-of-care, autologous cell-based therapies,
today announced that Dr. Xiaochun “Chris” Xu, interim chief
executive officer, will present at the 2017 Marcum MicroCap
Conference on Thursday, June 15, 2017, at the Grand Hyatt Hotel in
New York. Dr. Xu’s presentation is scheduled to begin at 9:00 AM.
To access a live webcast of the presentation,
please visit the Investors section of Cesca Therapeutics’ website,
www.cescatherapeutics.com, under the Webcasts tab. An archived
replay of the webcast will be available for 90 days.
About Cesca Therapeutics
Inc.Cesca is a leading regenerative medicine company that
develops, commercializes and markets a range of automated
technologies for cell-based therapeutics. Its device division,
ThermoGenesis, provides a full suite of solutions for automated
clinical biobanking, point-of-care applications, and automation for
immuno-oncology. Cesca is also leveraging its proprietary
AutoXpress® technology platform to develop autologous stem
cell-based therapies that address significant unmet needs in the
vascular, cardiology and orthopedic markets.
Cesca is an affiliate of the BoyaLife Group, a
China-based industry research alliance encompassing top research
institutions for stem cell and regenerative medicine.
Company Contact: Cesca Therapeutics Inc.
ir@cescatherapeutics.com
Investor Contact:
Rx Communications Group
Paula Schwartz
917-322-2216
pschwartz@rxir.com
Cesca Therapeutics (NASDAQ:KOOL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cesca Therapeutics (NASDAQ:KOOL)
Historical Stock Chart
From Apr 2023 to Apr 2024